COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents

Not Applicable

Withdrawn

• Conditions: Coronavirus

• Registration Number: NCT04542395
• Lead Sponsor: Charles Drew University of Medicine and Science

Brief Summary

This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to reduce barriers and implement innovate strategies to engage this population in the uptake of COVID-19 testing and vaccination.

Detailed Description

Through the engagement and empowerment of 15 trained COVID-19 health ambassadors, the investigators will jointly implement and evaluate a theoretically based and culturally-sensitive socio-behavioral intervention that will: a) reduce mistrust, fatalistic beliefs, and related psychosocial barriers that hinder COVID-19 testing and vaccination; b) increase receptivity and willingness for uptake of COVID-19 testing and vaccination; and c) assess perceived impact of psychosocial and health outcomes related to COVID-19 testing and vaccination for 310 African American and Latinx public housing residents.

Study Timeline

• Study First Submitted: 2020-09-03
• Study First Submitted QC: 2020-09-04
• Study First Posted: 2020-09-09
• Status Verified: 2022-08
• Last Update Submitted: 2022-08-17
• Last Update Posted: 2022-08-19
• Study Start: 2023-06-01
• Primary Completion: 2025-11-30
• Study Completion: 2025-11-30

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Identify as Latino/Hispanic or African American/Black
• Reside in one of the six collaborating public housing
• 18 years old and older
• Speak either English or Spanish

Exclusion Criteria

• Does not self-identify as African American and/or Black
• Under the age of 18
• Unable to speak English or Spanish
• Does not Reside in one of the six collaborating public housing

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Percentage of Participants Achieving Decreased Levels of COVID-19 Risk Using the NIH Toolbox Surveys on COVID-19	Intervention: 3 months; Follow-up Point: 6 months post-intervention	By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 30% change in perceived COVID-19 risk.
Percentage of Participants Achieving Decreased Levels of COVID-19 Mistrust and Barriers Using the NIH Toolbox Surveys on COVID-19	Intervention: 3 months; Follow-up Point: 6 months post-intervention	By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 40% change in mistrust and perceived barriers toward COVID-19 testing and vaccination,
Prevalence of COVID-19 testing, pneumococcal and influenza vaccinations Using Test History Self-Report	Intervention: 3 months; Follow-up Point: 6 months post-intervention	By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 30% change in willingness and uptake for testing and vaccination.

Trial Locations

Locations (1)

Housing Authority of Clty of Los Angeles; 🇺🇸 Los Angeles, California, United States